Record NNP B-NP O
date NN I-NP O
: : O O
2082-10-31 CD O B-DATE
Team NNP B-NP O
B NNP I-NP O
Internal NNP I-NP O
Medicine NNP I-NP O
Intern NNP I-NP O
Admission NNP I-NP O
Note NN I-NP O
Louise NNP B-NP B-PATIENT
Urquhart NNP I-NP I-PATIENT
MR# NNP B-NP O
2072665 CD I-NP B-MEDICALRECORD
Date NNP B-NP O
of IN B-PP O
Admission NNP B-NP O
: : O O
10/30/8 CD B-NP I-DATE
2 CD I-NP I-DATE
PCP NNP B-NP O
: : O O
Dr. NNP B-NP O
Tatyana NNP I-NP B-DOCTOR
Butler NNP I-NP I-DOCTOR
( -LRB- I-NP O
Solemar NNP I-NP B-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
) -RRB- O O
ID/CC NNP B-NP O
: : O O
75 CD B-NP B-AGE
yo NNP I-NP O
F NNP I-NP O
with IN B-PP O
HTN NNP B-NP O
, , O O
DM2 NNP B-NP O
, , O O
RCC NNP B-NP O
s/p RB B-ADVP O
right RB B-ADVP O
radical JJ B-NP O
nephrectomy NN I-NP O
2079 CD B-NP B-DATE
presents NNS I-NP O
with IN B-PP O
hypertensive JJ B-NP O
urgency NN I-NP O
HPI NNP B-NP O
: : O O
Has VBZ B-VP O
h/o IN B-PP O
HTN NNP B-NP O
, , O O
saw VBD B-VP O
her PRP$ B-NP O
PCP NN I-NP O
in IN B-PP O
September NNP B-NP B-DATE
, , O O
BP NNP B-NP O
168/78 CD I-NP O
, , O O
supposed VBN B-VP O
to TO I-VP O
be VB I-VP O
on IN B-PP O
cozaar NN B-NP O
50 CD I-NP O
mg NN I-NP O
BID NNP I-NP O
, , O O
added VBD B-VP O
HCTZ NNP B-NP O
25 CD I-NP O
mg NN I-NP O
QD. NNP I-NP O
However RB B-ADVP O
, , O O
patient NN B-NP O
has VBZ B-VP O
only RB I-VP O
been VBN I-VP O
taking VBG I-VP O
cozaar NN B-NP O
50 CD I-NP O
mg NN I-NP O
QD. NNP I-NP O
Needed VBD B-VP O
renewal NN B-NP O
of IN B-PP O
her PRP$ B-NP O
prescription NN I-NP O
, , O O
was VBD B-VP O
sent VBN I-VP O
to TO B-PP O
medical JJ B-NP O
walk NN I-NP O
in IN B-PP O
clinic NN B-NP O
prior JJ I-NP O
to TO B-PP O
filling VBG B-VP O
it PRP B-NP O
, , O O
found VBD B-VP O
BP NNP B-NP O
to TO B-VP O
be VB I-VP O
230/110 CD B-NP O
. . O O
Had VBD B-VP O
HA NNP B-NP O
2 CD B-NP O
nights NNS I-NP O
ago RB B-ADVP O
lasting JJ B-NP O
couple NN I-NP O
hours NNS I-NP O
, , O O
posterior JJ B-NP O
neck NN I-NP O
across IN B-PP O
top NN B-NP O
of IN B-PP O
head NN B-NP O
. . O O
While IN O O
in IN B-PP O
waiting VBG B-VP O
room NN B-NP O
also RB B-ADVP O
had VBD B-VP O
HA NNP B-NP O
, , O O
4/10 CD B-NP O
from IN B-PP O
back NN B-NP O
of IN B-PP O
neck NN B-NP O
across IN B-PP O
top NN B-NP O
of IN B-PP O
head NN B-NP O
. . O O
No DT B-NP O
other JJ I-NP O
sx NN I-NP O
- : O O
no DT B-NP O
CP CD I-NP O
, , O O
SOB NNP B-NP O
, , O O
visual JJ B-NP O
changes NNS I-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
unilateral JJ B-NP O
weakness NN I-NP O
, , O O
numbness NN B-NP O
, , O O
hematuria NN B-NP O
. . O O
Was VBD B-VP O
stressed VBN I-VP O
out RP B-ADVP O
over IN B-PP O
argument NN B-NP O
with IN B-PP O
granddaughter JJ B-NP O
yesterday NN I-NP O
. . O O
In IN B-PP O
ED VBN B-NP O
afebrile JJ I-NP O
T NNP I-NP O
96.5 CD I-NP O
, , O O
BP NNP B-NP O
235/92 CD I-NP O
, , O O
HR NNP B-NP O
91 CD I-NP O
, , O O
RR NNP B-NP O
18 CD I-NP O
. . O O
No DT B-NP O
evidence NN I-NP O
papilledema NN I-NP O
, , O O
no DT B-NP O
focal JJ I-NP O
neurologic NN I-NP O
signs NNS I-NP O
. . O O
EKG NN B-VP O
with IN B-PP O
new JJ B-NP O
TWI NNP I-NP O
V1-V4 NNP I-NP O
, , O O
head NN B-NP O
CT NNP I-NP O
and CC I-NP O
CXR NNP I-NP O
unremarkable JJ I-NP O
. . O O
Given VBN B-VP O
hydralazine NN B-NP O
10 CD I-NP O
mg NN I-NP O
IV NNP I-NP O
x NN I-NP O
2 CD B-NP O
, , O O
ativan IN B-ADVP O
1 CD B-NP O
mg NN I-NP O
IV NNP B-NP O
x1 CD I-NP O
, , O O
and CC O O
lopressor VBD B-VP O
25 CD B-NP O
mg NN I-NP O
PO NNP B-NP O
x1 CD I-NP O
, , O O
BP NNP B-NP O
improved VBD B-VP O
to TO B-PP O
160's/8 CD B-NP O
0 CD I-NP O
's POS B-NP O
. . O O
ROS NNP B-NP O
: : O O
No DT B-NP O
F/C/NS. NNP I-NP O
No DT B-NP O
change NN I-NP O
in IN B-PP O
weight/appetite NN B-NP O
. . O O
No DT B-NP O
CP/Palpitations/Orthopnea/PND/LE NNP I-NP O
edema/Claudication NN I-NP O
. . O O
No DT B-NP O
SOB/cough/hemoptysis/wheezing/sore JJ I-NP O
throat/rash NN I-NP O
. . O O
No DT B-NP O
N/V/D/hematochezia/melena NNP I-NP O
. . O O
No DT B-NP O
delta NN I-NP O
MS/LOC. . B-PP O
No DT B-NP O
slurring NN I-NP O
of IN B-PP O
speech NN B-NP O
, , O O
unilateral JJ B-NP O
weakness NN I-NP O
. . O O
No DT B-NP O
dysuria NN I-NP O
. . O O
+ '' O O
Right RB B-ADVP O
heel NN B-NP O
pain NN I-NP O
since IN B-PP O
jumping VBG B-VP O
to TO I-VP O
grab VB I-VP O
her PRP$ B-NP O
dog NN I-NP O
2 CD B-NP O
weeks NNS I-NP O
ago RB B-ADVP O
. . O O
Otherwise RB B-ADJP O
negative JJ I-ADJP O
in IN B-PP O
detail NN B-NP O
. . O O
PMH: . O O
HTN . O O
DM2 CD B-NP O
- : O O
x SYM B-VP O
5 CD B-NP O
yrs NNS I-NP O
, , O O
no DT B-NP O
retinopathy NN I-NP O
, , O O
nephropathy NN B-NP O
, , O O
neuropathy NN B-NP O
, , O O
HBA1C NNP B-NP O
7.2 CD I-NP O
7/26 CD O B-DATE
RCC NNP B-NP O
s/p RB B-ADVP O
right RB B-ADVP O
radical JJ B-NP O
nephrectomy NN I-NP O
2079 CD I-NP B-DATE
, , O O
4 CD B-NP O
cm NN I-NP O
, , O O
grade NN B-NP O
II/IV NNP I-NP O
, , O O
confined VBN B-VP O
in IN B-PP O
capsule NN B-NP O
S/p NNP B-NP O
colonoscopic NN I-NP O
polypectomy NN I-NP O
tubular JJ I-NP O
adenoma NN I-NP O
2079 CD O B-DATE
Diverticulosis NN B-NP O
Osteoporosis NN B-NP O
Medications NNS B-NP O
: : O O
Cozaar NNP B-NP O
50 CD I-NP O
mg NN I-NP O
PO NN I-NP O
BID NNP I-NP O
( -LRB- B-VP O
only RB I-VP O
taking VBG I-VP O
50 CD B-NP O
QD NN I-NP O
) -RRB- O O
HCTZ NNP B-NP O
25 CD I-NP O
mg , O O
PO NNP B-NP O
QD NNP I-NP O
(added VBD B-VP O
9/8 CD B-NP I-DATE
2 CD I-NP I-DATE
, , O O
not RB O O
taking VBG B-VP O
) -RRB- O O
Glyburide NNP B-NP O
5 CD I-NP O
mg NN I-NP O
PO NN I-NP O
QD . O O
Premarin NNP B-NP O
PO NNP I-NP O
QHS NNP I-NP O
( -LRB- B-VP O
not RB I-VP O
taking VBG I-VP O
) -RRB- O O
Fosamax NNP B-NP O
70 CD I-NP O
mg NN I-NP O
PO NN I-NP O
QWK NN I-NP O
( -LRB- B-VP O
not RB I-VP O
taking VBG I-VP O
) -RRB- O O
Ativan NNP B-NP O
0.5 CD I-NP O
mg NN I-NP O
PO NNP I-NP O
QD NNP I-NP O
PRN NNP I-NP O
Tums NNS B-NP O
MVI . O O
Allergies NNP B-NP O
: : O O
PCN NNP B-NP O
, , O O
sulfa NN B-NP O
rash NN I-NP O
, , O O
ACE-I JJ B-NP O
cough NN I-NP O
, , O O
codeine NN B-NP O
GI NN I-NP O
upset VBN O O
SH NNS B-NP O
: : O O
Patient NNP B-NP O
lives VBZ B-VP O
in IN B-PP O
Marianna NNP B-NP B-CITY
with IN B-PP O
husband NN B-NP O
of IN B-PP O
54 CD B-NP O
yrs NNS I-NP O
. . B-NP O
Used NN I-NP O
to TO B-VP O
work VB I-VP O
at IN B-PP O
Filenes NNP B-NP B-ORGANIZATION
as IN B-PP O
a DT B-NP O
salesperson NN I-NP B-PROFESSION
. . B-NP O
Son NN I-NP O
handicapped VBD B-VP O
after IN B-PP O
hit NN B-NP O
by IN B-PP O
drunk JJ B-NP O
driver NN I-NP O
9 CD B-NP O
yrs NNS I-NP O
ago RB B-ADVP O
, , O O
this DT B-NP O
remains VBZ B-VP O
a DT B-NP O
significant JJ I-NP O
stressor NN I-NP O
for IN B-PP O
her PRP B-NP O
. . O O
Tob NNP B-NP O
: : O O
Very RB B-ADJP O
rare JJ I-ADJP O
, , O O
quit VBD B-VP O
30 CD B-NP O
yrs NNS I-NP O
ago IN O O
EtOH NNP B-NP O
: : O O
Used JJ B-ADJP O
to TO B-VP O
drink VB I-VP O
occasional JJ B-NP O
glass NN I-NP O
wine NN I-NP O
, , O O
none NN B-NP O
recently RB B-ADVP O
Illicits NNS B-NP O
: : O O
Negative JJ O O
FH NNP B-NP O
: : O O
No DT B-NP O
MI NNP I-NP O
, , I-NP O
cancer NN I-NP O
. . O O
Brother '' O O
with IN B-PP O
poor JJ B-NP O
circulation NN I-NP O
. . O O
Exam NNP B-NP O
: : O O
VS NNP B-NP O
: : O O
T= NNP B-NP O
98.2 CD I-NP O
HR= NNP I-NP O
68 CD I-NP O
BP= NNP I-NP O
152/8 CD I-NP O
1 CD I-NP O
RR= NN I-NP O
18 CD O O
General NNP B-NP O
: : O O
NAD NNP B-NP O
, , O O
well RB B-ADVP O
appearing VBG O O
HEENT NNP B-NP O
: : O O
NC/AT NN B-NP O
, , O O
PERRL NNP B-NP O
, , O O
anicteric JJ B-ADJP O
. . B-NP O
EOMI NNP I-NP O
. . O O
Fundi NNP B-NP O
poorly RB B-ADVP O
visualized VBD B-VP O
. . B-NP O
OP NNP I-NP O
w/ VBD B-VP O
MMM NNP B-NP O
, , O O
no DT B-NP O
erythema NN I-NP O
or CC I-NP O
injection NN I-NP O
. . O O
Skin NNP B-NP O
: : O O
No DT B-NP O
rashes NNS I-NP O
Neck NNP B-NP O
: : O O
Supple NN B-NP O
, , O O
full JJ B-NP O
ROM NNP I-NP O
, , O O
no DT B-NP O
JVD NNP I-NP O
, , O O
2+ CD B-NP O
carotids NNS I-NP O
w/o IN B-PP O
bruits NNS B-NP O
, , O O
no DT B-NP O
thyromegaly NN I-NP O
or CC I-NP O
nodules NNS I-NP O
, , O O
no DT B-NP O
nodes NNS I-NP O
Chest NNP B-NP O
: : O O
CTA&P NNP B-NP O
bilaterally CC O O
CVS NNP B-NP O
: : O O
RRR NNP B-NP O
nl , O O
S1 NNP B-NP O
S2 NNP I-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
Abd NNP B-NP O
: : O O
nl JJ B-NP O
BS NNP I-NP O
, , O O
soft JJ B-NP O
, , I-NP O
non-tender JJ I-NP O
, , O O
no DT B-NP O
HSM NNP I-NP O
, , O O
no DT B-NP O
abdominal NN I-NP O
bruits NNS I-NP O
Extr NNP B-NP O
: : O O
no DT B-NP O
c/c/e NN I-NP O
2+ IN B-PP O
DP NNP B-NP O
's POS B-NP O
bilaterally NN I-NP O
Neuro NNP B-NP O
: : O O
AAOX3 NNP B-NP O
, , O O
MS NNP B-NP O
nl NN I-NP O
, , O O
CN NNP B-NP O
II NNP I-NP O
through IN B-PP O
XII NNP B-NP O
intact JJ I-NP O
, , O O
Motor NNP B-NP O
5/5 VBD B-VP O
UE NNP B-NP O
and CC I-NP O
LE JJ I-NP O
, , O O
Sensory NNP B-NP O
intact JJ I-NP O
to TO B-PP O
LT NNP B-NP O
, , O O
vibration NN B-NP O
sense NN I-NP O
distally RB B-ADVP O
. . O O
F PRP B-ADJP O
to TO B-PP O
N NNP B-NP O
nl NN I-NP O
, , O O
RAM NNP B-NP O
nl NN I-NP O
. . O O
DATA NNP B-NP O
: : O O
Chemistry NN B-NP O
: : O O
SH NNS B-NP B-HOSPITAL
BLOOD NNP I-NP O
30-Oct-2082 CD I-NP B-DATE
19:57 CD O O
Plasma NNP B-NP O
Sodium NNP I-NP O
133 CD I-NP O
L NNP B-NP O
135-145 CD I-NP O
mmol/L . O O
Plasma NN B-NP O
Potassium NNP I-NP O
5.4 CD I-NP O
H NNP B-NP O
3.4-4.8 CD I-NP O
mmol/L . O O
Plasma NNP B-NP O
Chloride NNP I-NP O
98 CD I-NP O
L NNP B-NP O
100-108 CD I-NP O
mmol/L . O O
Plasma NNP B-NP O
Carbon NNP I-NP O
Dioxide NNP I-NP O
26.6 CD I-NP O
24.0-30.0 CD I-NP O
mmol/L . O O
Calcium NNP B-NP O
10.4 CD I-NP O
8.5-10.5 CD I-NP O
mg/dl NN I-NP O
Phosphorus NNP B-NP O
2.4 CD I-NP O
L NNP I-NP O
2.6-4.5 CD I-NP O
mg/dl NN I-NP O
Magnesium NNP B-NP O
1.6 CD I-NP O
1.4-2.0 CD I-NP O
meq/L NNS I-NP O
Plasma NNP B-NP O
Urea NNP I-NP O
Nitrogen NNP I-NP O
18 CD I-NP O
8-25 CD I-NP O
mg/dl NN I-NP O
Plasma NNP B-NP O
Creatinine NNP I-NP O
1.1 CD I-NP O
0.6-1.5 CD I-NP O
mg/dl . O O
Plasma NNP B-NP O
Glucose NNP I-NP O
230 CD I-NP O
H NNP B-NP O
70-110 CD I-NP O
mg/dl . O O
Total JJ B-NP O
Protein NNP I-NP O
8.2 CD I-NP O
H NNP B-NP O
6.0-8.0 CD I-NP O
g/dl . O O
Albumin NNP B-NP O
4.0 CD I-NP O
3.1-4.3 CD I-NP O
g/dl NN I-NP O
Globulin NNP B-NP O
4.2 CD I-NP O
H NNP B-NP O
2.6-4.1 CD I-NP O
g/dl . O O
Direct JJ B-NP O
Bilirubin NNP I-NP O
0.2 CD I-NP O
0-0.4 CD I-NP O
mg/dl NN I-NP O
Total JJ B-NP O
Bilirubin NNP I-NP O
0.4 CD I-NP O
0-1.0 CD I-NP O
mg/dl NN I-NP O
Alkaline NNP B-NP O
Phosphatase NNP I-NP O
94 CD I-NP O
30-100 CD I-NP O
U/L . O O
Transaminase-SGPT NNP B-NP O
27 CD I-NP O
7-30 CD I-NP O
U/L . O O
Transaminase-SGOT NNP B-NP O
53 CD I-NP O
H NNP B-NP O
9-25 CD I-NP O
U/L . O O
Creatine JJ B-NP O
Kinase NNP I-NP O
108 CD I-NP O
40-150 CD I-NP O
U/L . O O
SH NNS B-NP B-HOSPITAL
BLOOD NNP I-NP O
30-Oct-2082 CD I-NP B-DATE
23 CD I-NP O
:10 . O O
Creatine NNP B-NP O
Kinase NNP I-NP O
Isoenzy NNP I-NP O
1.9 CD I-NP O
0.0-6.9 CD I-NP O
ng/ml NN I-NP O
Troponin-T NNP B-NP O
<0.01 CD I-NP O
0.00-0.09 CD I-NP O
ng/ml NN I-NP O
Creatine JJ B-NP O
Kinase NNP I-NP O
203 CD I-NP O
H NNP B-NP O
40-150 CD I-NP O
U/L . O O
Heme NNP B-NP O
: : O O
SH NNS B-NP B-HOSPITAL
BLOOD NNP I-NP O
30-Oct-2082 CD I-NP B-DATE
19:52 CD O O
WBC NNP B-NP O
14.2 CD I-NP O
H NNP B-NP O
4.5-11.0 CD I-NP O
th/cmm . O O
HCT NNP B-NP O
42.0 CD I-NP O
36.0-46.0 CD I-NP O
% NN I-NP O
HGB NNP B-NP O
14.2 CD I-NP O
12.0-16.0 CD I-NP O
gm/dl NN I-NP O
RBC NNP B-NP O
4.78 CD I-NP O
4.00-5.20 CD I-NP O
mil/cmm . O O
PLT NNP B-NP O
220 CD I-NP O
150-350 CD I-NP O
th/cumm . O O
MCV RB B-NP O
88 CD I-NP O
80-100 CD I-NP O
fl NN I-NP O
MCH NNP B-NP O
29.7 CD I-NP O
26.0-34.0 CD I-NP O
pg/rbc NN I-NP O
MCHC NNP B-NP O
33.8 CD I-NP O
31.0-37.0 CD I-NP O
g/dl NN I-NP O
RDW NNP B-NP O
12.8 CD I-NP O
11.5-14.5 CD I-NP O
% NN I-NP O
DIFFERENTIAL NNP B-NP O
REQUEST NNP I-NP O
RECEIVED NNP I-NP O
Diff JJ B-NP O
Method NNP I-NP O
Auto NN I-NP O
Poly NNP B-NP O
71 CD I-NP O
H NNP I-NP O
40-70 CD I-NP O
% NN I-NP O
Lymphs NNP B-NP O
23 CD I-NP O
22-44 CD I-NP O
% NN I-NP O
Monos NNP B-NP O
3 CD I-NP O
L NNP I-NP O
4-11 CD I-NP O
% NN I-NP O
EOS NNP B-NP O
2 CD I-NP O
0-8 CD I-NP O
% NN I-NP O
Basos NNS B-NP O
1 CD B-NP O
0-3 CD I-NP O
% NN I-NP O
Absolute JJ B-NP O
Neuts NNP I-NP O
10.27 CD I-NP O
H NNP B-NP O
1.8-7.7 CD I-NP O
th/cmm . O O
Absolute JJ B-NP O
Lymphs NNP I-NP O
3.20 CD I-NP O
1.0-4.8 CD I-NP O
th/cmm . O O
Absolute JJ B-NP O
Monos NNP I-NP O
0.46 CD I-NP O
H NNP B-NP O
0.2-0.4 CD I-NP O
th/cmm . O O
Absolute JJ B-NP O
EOS NNP I-NP O
0.22 CD I-NP O
0.1-0.3 CD I-NP O
th/cmm . O O
Absolute JJ B-NP O
Basos NNP I-NP O
0.07 CD I-NP O
0.0-0.3 CD I-NP O
th/cmm . O O
Urinalysis NNP B-NP O
: : O O
Pending VBG O O
Microbiology NNP B-NP O
: : O O
None NN B-NP O
CXR NN B-NP O
: : O O
Official NNP B-NP O
read VBD B-VP O
pending VBG B-NP O
, , O O
no DT B-NP O
infiltrates NNS I-NP O
, , O O
CHF NNP B-NP O
Head NNP B-NP O
CT NNP I-NP O
: : O O
FINDINGS NNS B-NP O
: : O O
Dystrophic JJ B-NP O
calcification NN I-NP O
in IN B-PP O
the DT B-NP O
basal NN I-NP O
ganglia NN I-NP O
bilaterally RB B-ADVP O
. . O O
Head '' O O
CT NNP B-NP O
otherwise RB B-ADVP O
negative JJ B-ADJP O
. . O O
No DT B-NP O
intracranial JJ I-NP O
hemorrhage NN I-NP O
, , O O
mass NN B-NP O
, , O O
mass NN B-NP O
effect NN B-NP O
, , O O
or CC O O
edema NN B-NP O
. . O O
No DT B-NP O
gross JJ I-NP O
evidence NN I-NP O
of IN B-PP O
acute JJ B-NP O
infarction NN I-NP O
, , O O
although IN B-SBAR O
MRI NNP B-NP O
with IN B-PP O
diffusion NN B-NP O
weighted VBN I-NP O
imaging NN I-NP O
would MD B-VP O
be VB I-VP O
more RBR B-ADJP O
sensitive JJ I-ADJP O
. . O O
Intracranial NNP B-NP O
arterial NN I-NP O
calcification NN I-NP O
. . O O
Bilateral JJ B-NP O
lens NN I-NP O
implants NNS I-NP O
. . O O
IMPRESSION NN B-NP O
: : O O
Essentially RB B-ADVP O
normal JJ B-NP O
head NN I-NP O
CT. . O O
EKG NNP B-NP O
: : O O
NSR NNP B-NP O
90 CD I-NP O
BPM NNP I-NP O
, , O O
nl NN B-NP O
intervals NNS I-NP O
, , O O
nl JJ B-NP O
axis NN I-NP O
, , O O
deepening VBG B-VP O
of IN B-PP O
old JJ B-NP O
TWI NNP I-NP O
aVL NN I-NP O
, , O O
new JJ B-NP O
TWI NNP I-NP O
V1-V4 NNP I-NP O
, , O O
isolated VBD B-VP O
q NNP B-NP O
in IN B-PP O
III NNP B-NP O
Impression NN B-NP O
: : O O
75 CD B-NP B-AGE
yo NNP I-NP O
F NNP I-NP O
with IN B-PP O
HTN NNP B-NP O
, , O O
DM2 NNP B-NP O
, , O O
RCC NNP B-NP O
s/p RB B-ADVP O
right RB B-ADVP O
radical JJ B-NP O
nephrectomy NN I-NP O
2079 CD B-NP B-DATE
presents NNS I-NP O
with IN B-PP O
hypertensive JJ B-NP O
urgency NN I-NP O
. . O O
Not RB B-VP O
taking VBG I-VP O
all DT B-NP O
of IN B-PP O
prescribed VBN B-NP O
meds NNS I-NP O
. . O O
Could MD B-VP O
have VB I-VP O
left VBN I-VP O
sided VBN I-VP O
renal JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
exacerbating VBG B-VP O
HTN NNP B-NP O
in IN B-PP O
setting VBG B-VP O
of IN B-PP O
unilateral JJ B-NP O
kidney NN I-NP O
, , O O
K NNP B-NP O
is VBZ B-VP O
elevated VBN I-VP O
, , O O
although IN B-SBAR O
Cr NNP B-NP O
normal JJ I-NP O
on IN B-PP O
cozaar NN B-NP O
. . O O
Needs NNS B-VP O
tight JJ B-NP O
BP NNP I-NP O
control NN I-NP O
esp VBP B-VP O
in IN B-PP O
setting NN B-NP O
of IN B-PP O
DM NNP B-NP O
to TO B-VP O
prevent VB I-VP O
nephrosclerosis NN B-NP O
. . O O
Plan NNP B-NP O
: : O O
HTN NNP B-NP O
- : O O
BP NNP B-VP O
now RB B-ADVP O
better RB B-VP O
controlled VBN I-VP O
, , O O
cont NN B-NP O
to TO B-PP O
cycle NN B-NP O
q1 IN B-PP O
hr NN B-NP O
for IN B-PP O
now RB B-NP O
. . O O
Will MD B-VP O
repeat VB I-VP O
EKG NNP B-NP O
, , I-NP O
ROMI NNP I-NP O
with IN B-PP O
serial JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
. . O O
ASA NNP B-NP O
, , O O
monitor NN B-NP O
. . O O
Cont NN B-NP O
cozaar NN I-NP O
50 CD I-NP O
mg NN I-NP O
qd NN I-NP O
( -LRB- I-NP O
may MD B-VP O
need VB I-VP O
to TO I-VP O
d/c VB I-VP O
or CC I-VP O
decrease VB I-VP O
dose NN B-NP O
if IN B-SBAR O
K NNP B-NP O
remains VBZ B-VP O
elevated JJ B-ADJP O
) -RRB- O O
and CC O O
start VB B-VP O
lopressor VB I-VP O
25 CD B-NP O
TID NNP I-NP O
and CC O O
titrate VB B-VP O
up RP B-PRT O
as IN B-NP O
needed VBN B-VP O
for IN B-PP O
BP NNP B-NP O
control NN I-NP O
. . O O
Will MD B-VP O
not RB I-VP O
attempt VB I-VP O
to TO I-VP O
lower VB I-VP O
BP NNP B-NP O
beyond IN B-PP O
150-160 CD B-NP O
's VBZ B-VP O
for IN B-PP O
now RB B-ADVP O
to TO B-VP O
prevent VB I-VP O
drop NN B-NP O
in IN B-PP O
cerebral JJ B-NP O
perfusion NN I-NP O
pressure NN I-NP O
. . O O
Cont NNP O O
ativan IN B-PP O
0.5-1 CD B-NP O
mg NN I-NP O
PO NNP I-NP O
BID NNP I-NP O
PRN. NNP I-NP O
Consider VB B-VP O
MRI/MRA NNP B-NP O
to TO B-VP O
assess VB I-VP O
for IN B-PP O
RAS NNS B-NP O
given VBN B-VP O
such JJ B-NP O
severe JJ I-NP O
BP NNP I-NP O
elevation NN I-NP O
. . O O
Strict VB B-VP O
I/O CC I-VP O
's POS I-VP O
. . O O
F/E/N NNP B-NP O
- : O O
Kayexalate JJ B-NP O
30g JJ I-NP O
x NN I-NP O
1 CD I-NP O
, , I-NP O
recheck NN I-NP O
K NNP I-NP O
in IN B-PP O
AM NNP B-NP O
, , O O
consider VBP B-VP O
lasix RB B-ADVP O
. . O O
DM NNP B-NP O
- : O O
Cont JJ B-NP O
glyburide NN I-NP O
, , O O
check NN B-NP O
QID VBD B-VP O
FS NNS B-NP O
with IN B-PP O
insulin NN B-NP O
SS. NNP I-NP O
Diabetic NNP I-NP O
diet NN I-NP O
Proph NNP B-NP O
- : O O
Nexium NNP B-NP O
, , O O
SC NNP B-NP O
heparin NN I-NP O
Xander NNP B-NP B-DOCTOR
H. NNP I-NP I-DOCTOR
Leonard NNP I-NP I-DOCTOR
, , O O
MD NNP B-NP O
Pager NNP B-NP O
# # I-NP O
77615 CD O B-PHONE
